Drugs
Tampa Electric Co. and Florida Power Corp. announced rate changes for the year 2000, reflecting adjustments in fuel costs. Tampa Electric's rates will increase by about $2 a month, while Florida Power's rates will decrease by $1 annually. The Public Service Commission has approved these changes,
Drugs
The collaboration will enable the companies to combine world-class combinatorial chemistry expertise and expand their chemistry capacity in North America. Cambridge Discovery Chemistry will take over responsibility for Zeneca's chemistry research facility in Richmond, California, and the partnership will provide flexibility in managing the level of resources required
Drugs
American Home Products' advisers have made a secret approach to Pharmacia & Upjohn's advisers, suggesting a takeover of P&U if AHP's deal with Warner-Lambert falls through. This move comes after Pfizer launched an unsolicited bid for Warner-Lambert, making AHP's merger attempt
Drugs
Warner-Lambert's shareholders may gain clarity on the proposed merger with American Home Products before they vote on May 15, thanks to a trial scheduled for April 10 in the Delaware Court of Chancery. The dispute revolves around the blockbuster cholesterol-fighting drug Lipitor, with Warner-Lambert seeking to terminate its
Drugs
SAP's reputation for lengthy implementation and validation processes is being challenged by a firm in suburban Philadelphia that has created preconfigured systems to accelerate the process. The pharmaceutical solution architect at SAP America, Dr. Joseph Cardarelli, notes that the preconfigured systems integrate the best business practices in the
Drugs
The Strategic Research Institute is hosting a comprehensive conference on food labeling and health-related claims, scheduled for January 28-29, 2000, at the Wyndham Washington D.C. The event will feature insightful keynote presentations, mini-workshops, and panel discussions led by renowned experts in the field. Keynote speakers include Peter Barton Hutt,
Drugs
Pfizer's latest move to pursue relief in court despite failing to present clear facts has left Warner-Lambert Company questioning the validity of their claims. In response to a complaint filed by Pfizer, Warner-Lambert emphasizes the intentional misrepresentation of the parties' standstill agreement by Pfizer. Warner-Lambert highlights the
Drugs
Warner-Lambert is gearing up to file a lawsuit to terminate its co-marketing agreement with Pfizer for the blockbuster anti-cholesterol drug Lipitor, amidst a high-stakes battle over Pfizer's unsolicited $72 billion bid. The move, which could see Warner-Lambert regain total control of Lipitor, has been deemed a high-risk strategy
Drugs
As the battle for control of Warner-Lambert Co. intensifies, the company is threatening to sever its contract with Pfizer Co. to co-market the blockbuster anti-cholesterol drug Lipitor, a move that could have significant implications for both companies. Meanwhile, global mergers and acquisitions continue to heat up, with Deutsche Post AG
Drugs
Warner-Lambert Company, a global pharmaceutical and consumer health care company, has announced significant steps in response to actions taken by Pfizer Inc related to their pending business combination. The company is reviewing Pfizer's actions to determine the best interests of Warner-Lambert's shareholders and considering termination of
Drugs
British hospitals are using hundreds of testing kits for cancer and heart disease, which have been banned in the US due to manufacturing problems. Abbott Laboratories, the largest maker of diagnostic tests, was fined $100 million by the US Food and Drug Administration (FDA) after failing to comply with quality
Drugs
Abbott Laboratories, a global, diversified health care company, has reached an agreement to sell its agricultural products business to Sumitomo Chemical Co., Ltd. of Tokyo, Japan. This strategic move allows Abbott to focus on the growth of its core health care businesses, while Sumitomo acquires research and development, sales, marketing,
